Mus musculus
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA279421 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR1930034.fastq.gz | Fastqsanger.gz | |||
| SRR1930035.fastq.gz | Fastqsanger.gz | |||
| SRR1930036.fastq.gz | Fastqsanger.gz | |||
| SRR1930037.fastq.gz | Fastqsanger.gz | |||
| SRR1930038.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 6 |
Similar Datasets
Project description:Length-dependent gene misregulation in Rett syndrome (ChIP-seq)
| PRJNA257416 | ENA
Project description:Length-dependent gene misregulation in Rett syndrome (Bisulfite-seq)
| PRJNA257415 | ENA
Project description:Length-dependent gene misregulation in Rett syndrome (Dnmt3a)
| PRJNA257419 | ENA
Project description:Length-dependent gene misregulation in Rett syndrome (MeCP2)
| PRJNA257421 | ENA
Project description:Length-dependent gene misregulation in Rett syndrome (Bisulfite-Seq 2)
| PRJNA279423 | ENA
Project description:Length-dependent gene misregulation in Rett syndrome (ChIP-Seq 2)
| PRJNA279422 | ENA
Project description:Disruption of the MECP2 gene leads to Rett syndrome (RTT), a severe neurological disorder with features of autism. MECP2 encodes a methyl-DNA-binding protein that is proposed to function as a transcriptional repressor, but, despite numerous studies examining neuronal gene expression in MeCP2 mutants, no coherent model has emerged for how MeCP2 regulates transcription. Here we identify a genome-wide length-dependent increase in the expression of long genes in neurons lacking MeCP2. This gene misregulation occurs in human RTT brains and correlates with onset and severity of phenotypes in Mecp2 mutant mice, suggesting that the disruption of long gene expression contributes to RTT pathology. We present evidence that MeCP2 represses long genes by binding to brain-enriched, methylated CA dinucleotides within genes and show that loss of methylated CA in the brain recapitulates gene expression defects observed in MeCP2 mutants. We find that long genes encode proteins with neuronal functions, and overlap substantially with genes that have been implicated in autism and Fragile X syndrome. Reversing the overexpression of long genes in neurons lacking MeCP2 can improve some RTT-associated cellular deficits. These findings suggest that a function of MeCP2 in the mammalian brain is to temper the expression of genes in a length-dependent manner, and that mutations in MeCP2 and possibly other autism genes may cause neurological dysfunction by disrupting the expression of long genes in the brain. MeCP2 ChIP-seq from the forebrain and cerebellum of wild-type mice.
2015-03-12 | E-GEOD-60071 | biostudies-arrayexpress
Project description:Disruption of the MECP2 gene leads to Rett syndrome (RTT), a severe neurological disorder with features of autism. MECP2 encodes a methyl-DNA-binding protein that is proposed to function as a transcriptional repressor, but, despite numerous studies examining neuronal gene expression in MeCP2 mutants, no coherent model has emerged for how MeCP2 regulates transcription. Here we identify a genome-wide length-dependent increase in the expression of long genes in neurons lacking MeCP2. This gene misregulation occurs in human RTT brains and correlates with onset and severity of phenotypes in Mecp2 mutant mice, suggesting that the disruption of long gene expression contributes to RTT pathology. We present evidence that MeCP2 represses long genes by binding to brain-enriched, methylated CA dinucleotides within genes and show that loss of methylated CA in the brain recapitulates gene expression defects observed in MeCP2 mutants. We find that long genes encode proteins with neuronal functions, and overlap substantially with genes that have been implicated in autism and Fragile X syndrome. Reversing the overexpression of long genes in neurons lacking MeCP2 can improve some RTT-associated cellular deficits. These findings suggest that a function of MeCP2 in the mammalian brain is to temper the expression of genes in a length-dependent manner, and that mutations in MeCP2 and possibly other autism genes may cause neurological dysfunction by disrupting the expression of long genes in the brain. Bisulfite-seq from mouse cortex and cerebellum
2015-03-12 | E-GEOD-60062 | biostudies-arrayexpress
Project description:Several recent studies have suggested that genes that are over 100 kb in length are particularly likely to be misregulated in neurological diseases associated with synaptic dysfunction, such as autism, Fragile X syndrome, and Rett syndrome. These length-dependent transcriptional changes seem to be modest, but, given the low sensitivity of high-throughput transcriptome profiling technology, the statistical significance of these results needs to be reevaluated. Here we show that transcriptional changes reflected in microarray and RNA-Sequencing benchmark datasets from the SEQC Consortium show a bias toward genes of greater length, even in the comparison of technical replicates. We hypothesized that PCR amplification, which is used in both microarray and RNA-Seq technologies, could be introducing this bias. We found that, when the fold-change values are small, PCR amplification in microarray and RNA-Seq technologies does produce a bias toward longer genes; we found no similar bias with nCounter technology, which is not based on PCR amplification. We provide an approach to more rigorously assess length-dependent changes that begins with comparing randomized control samples to estimate baseline gene length dependency and evaluate the statistical significance of gene length regulation.
2018-06-05 | GSE94073 | GEO